Retrospective Study The Journal of otolaryngology 2005

Sudden sensorineural hearing loss: our experience in diagnosis, treatment, and outcome.

Cadoni G, Agostino S, Scipione S, Ippolito S, Caselli A, Marchese R, et al. — The Journal of otolaryngology, 2005

View Original on PubMed PMID 16343399

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers retrospectively reviewed the charts of 156 inpatients diagnosed with sudden sensorineural hearing loss (SSNHL) at a single institution between 1987 and 2000.

What They Found

An etiologic factor was identified in 23 of 156 (15%) cases of sudden sensorineural hearing loss (SSNHL), with 143 patients receiving multidrug therapy and 13 receiving hyperbaric oxygen. Poor recovery was significantly associated with male sex, the presence of both tinnitus and vertigo, and the initial severity of hearing loss.

Canadian Relevance

This study was conducted in a single institution outside of Canada, so its direct applicability to the Canadian healthcare context is limited.

Study Limitations

As a retrospective study from a single institution, these findings may not be generalizable to all sudden sensorineural hearing loss patients.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type	Retrospective Study
Category	Sudden Hearing Loss
Source	Pubmed
PubMed ID	16343399
Year Published	2005
Journal	The Journal of otolaryngology
MeSH Terms	Adolescent; Adult; Aged; Audiometry, Pure-Tone; Auditory Threshold; Child; Female; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors

Related Research

Undersea Hyperb Med | 2021 Review

Hyperbaric oxygen for refractory osteomyelitis

Hart BB, Wilson BM, Shao Z, et al.

Biomed Pharmacother | 2018 Review

Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections

Memar MY, Yekani M, Alizadeh N, et al.

Am J Surg | 2005 Review

Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis

Jallali N, Withey S, Butler PE.

Eur J Surg Suppl | 1993 Clinical Study

Hyperbaric oxygen in the treatment of gas gangrene and perineal necrotizing fasciitis: a clinical and experimental study

Hirn M, Niinikoski J, Lehtonen OP.

Ann Chir Gynaecol | 2000 Clinical Study

Hyperbaric oxygen therapy in acute necrotizing infections with a special reference to the effects on tissue gas tensions

Korhonen K, Kuttila K, Niinikoski J.

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

See all Sudden Hearing Loss research

View on PubMed Back to Research Library

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology